Measurement of Na⁺ ratio in the TE and blastocyst cross-sectional area in the ouabain-treated group. by Ayaka Fujishima (21221913)

“…In the ouabain-treated group, the primary trend observed was a minimal increase in the blastocyst cross-sectional area. The Na⁺ concentration patterns were categorized into two main types: a decrease followed by an increase (Embryo Nos. 1, 3, 7, 9), and no significant change in Na⁺ concentration (Embryo Nos. 2, 4, 6, 8). …”

Selection of crossing point. by Yanchun Li (248761)

Means, standard deviations, and inferential statistics for the outcomes in the three conditions tested. by Robert Trybulski (10998702)

Subjects:

Leg Stabilization During Measurements arterial occlusion pressure. by Robert Trybulski (10998702)

Subjects:

Example of LDF recording during post-occlusive reactive hyperemia (PORH). by Robert Trybulski (10998702)

Subjects:

CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

Subjects:

Mean values and 95% confidence intervals for resting flow, arterial occlusion pressure (AOP), biological zero, reactive hyperemia (RHmax), and time to peak across the three conditi... by Robert Trybulski (10998702)

Subjects:

a) Number weighted mean volume of AEII during postnatal development and in adults. There are no volume alterations before and at the end of bulk alveolarization. A significant increase was determined in adults compared to 3 and 7 days old pups. b) Size of AEII presented as V_S-ratioAEII during postnatal lung development into adulthood. Before and during bulk alveolarization there are no size changes. Adults show a significant increase compared to values before and at onset of alveolarization. c) Number weighted mean volume of AEII per lung volume during postnatal development and in adults. The highest values are seen before alveolarization. During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21.... by Julia Hüttmann (22656283)

“…During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21. …”

Association between smoking status and incidence of cardiovascular and mortality outcomes stratified by enrollment year. by Erfan Tasdighi (9144667)

Subjects:

Baseline characteristics across conventional cigarette use status. by Erfan Tasdighi (9144667)

Subjects:

Graded association between pack-year groups in former and current smokers and cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Subjects:

Association between pack years of smoking and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline analysis. by Erfan Tasdighi (9144667)

Subjects:

CVD and mortality outcomes hazard ratio (HR) by years since quit smoking among former smokers compared with current and never smokers. by Erfan Tasdighi (9144667)

Subjects:

Cessation duration and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

Subjects:

Association between smoking status and incidence of cardiovascular and mortality outcomes among men. by Erfan Tasdighi (9144667)

Subjects:

Relationship between cigarettes per day and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

Subjects:

Association between the number of cigarettes per day with cardiovascular outcomes among current cigarette users. by Erfan Tasdighi (9144667)

Subjects:

Cessation duration and pack-years concurrent effect on the hazard ratio (HR) for cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Subjects:

Association between smoking Status and Incidence of cardiovascular and mortality outcomes among women. by Erfan Tasdighi (9144667)

Subjects:

Differential miRNA target gene pathway enrichment bubble map. by Zhaowen Tan (12283502)

Subjects: